compare glp 1 agonists Comparison of adverse effects between GLP-1 receptor GLP-1 medications compared: Benefits and

Fact : Actually, these drugs are very safe as proven by extensive clinical testing

2,6 The Australian evidence-based clinical guidelines for diabetes recommend GLP-1RAs as an add-on therapy in patients with cardiovascular disease, multiple cardiovascular risk factors or kidney disease, and intolerance or a contraindication to sodium-glucose cotransporter 2 (SGLT-2) inhibitors

GLP-1 Receptor Agonist Market Size The global GLP-1 receptor agonist market size was valued at USD 24.4 billion in 2023 and is expected to grow at 9.7% CAGR from 2024 to 2032, driven by rising incidences of type 2 diabetes and obesity globally

Mark Clements Lost over 170 lbs *Personal results may vary based on our individualized health programs

doi: 10.2337/db11-1556

Adverse effects included: Severe hypoglycaemia , acute pancreatitis and gastrointestinal side effects